COVID-19 Course in Allergic Asthma Patients: A Spanish Cohort Analysis

References

• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2 [published online ahead of print, 2020 Apr 22]. J Allergy Clin Immunol. 2020;S0091-6749(20):30551.
   Google Scholar
• Zhu J, Message SD, Mallia P, et al. Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations. J Allergy Clin Immunol. 2019;143(1):114–125.e4. doi:10.1016/j.jaci.2018.04.003
   PubMed Web of Science ®Google Scholar
• Wang JY, Pawanker R, Tsai HG, et al. COVID-19 and asthma, the good or the bad? Allergy. 2020. doi:10.1111//all.14480
   Google Scholar
• Liu S, Zhi Y, Ying S. COVID-19 and asthma: reflection during the pandemic. Clin Rev Allergy Immunol. 2020;59(1):78–88. doi:10.1007/s12016-020-08797-3
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Farner R, Sibila O, et al. Do chronic respiratory disease or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8:436–438. doi:10.1016/S2213-2600(20)30167-3
   PubMed Web of Science ®Google Scholar
• Zhao Q, Meng M, Kumar R, et al. The impact of COPD and smoking history on the severity of Covid-19: a systemic review and meta-analysis. J Med Virol. 2020;25889:1915–1921.
   Web of Science ®Google Scholar
• Zhu Z, Hasegawa K, Ma B, Fujiogi M, Camargo CA Jr, Liang L. Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 2020;146:327–329. doi:10.1016/j.jaci.2020.06.001
   PubMed Web of Science ®Google Scholar
• Ren J, Pang W, Luo Y, Cheng D, Qiu K, Rao Y. Impact of allergic Rhinitis and asthma on COVID-19 infection, hospitalization, and mortality. J Allergy Clin Immunol Pract. 2021; 10(1):124–133.
   PubMed Web of Science ®Google Scholar
• Guía española para el manejo del asma 5.0. Available from: www.gemasma.com. Accessed February 9, 2022.
   Google Scholar
• Izquierdo JL, Almonacid C, González Y, et al. The impact of COVID-19 on patients with asthma. Eur Respir J. 2021;57:2003142. doi:10.1183/13993003.03142-2020
   PubMed Web of Science ®Google Scholar
• Ferastraoaru D, Hudes G, Jershow E, Jariwala S, Karagic M, de Vos G. Eosinophilia in asthma patients is protective against severe COVID-19 illness. J Allergy Clin Immunol Pract. 9:1152–1162.
   PubMed Web of Science ®Google Scholar
• Wakabyashi M, Pawankar R, Narazaki H, Uede T, Itabashi T. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions. Curr Opin Allergy Clin Immunol. 2021;21(1–7):1152–1163.
   Web of Science ®Google Scholar
• Yang JM, Koh HY, Moon SY, et al. Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study. J Allergy Clin Immunol. 2020;146(4):790–798. doi:10.1016/j.jaci.2020.08.008
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. doi:10.1038/s41586-020-2521-4
   PubMed Web of Science ®Google Scholar
• Iwalski ML, Agache I, Bavbek S, et al. Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD) – a EAACI position paper. Allergy. 2019;74:28–39. doi:10.1111/all.13599
   PubMed Web of Science ®Google Scholar
• Díaz-Campos RM, García-Moguel I, Pina-Maiquez I, Fernández-Rodríguez C, Melero-Moreno C. Prevalence and influence of COVID-19 in asthma control and lung function in severe asthma patients receiving biological treatment. J Investig Allergol Clin Immunol. 2021;31(4):362–363. doi:10.18176/jiaci.0695
   PubMed Web of Science ®Google Scholar
• Kaye L, Theye B, Smeenk I, Gondalia R, Barrett MA, Stempel DA. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020;8(7):2384–2385. doi:10.1016/j.jaip.2020.04.053
   PubMed Web of Science ®Google Scholar
• Yamaya M, Nishimura H, Deng X, et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig. 2020;58(3):155–168. doi:10.1016/j.resinv.2019.12.005
   PubMed Web of Science ®Google Scholar
• Iwabuchi K, Yoshie K, Kurakami Y, Takahashi K, Kato Y, Morishima T. Therapeutic potential of ciclesonide inhalation for COVID-19 pneumonia: report of three cases. J Infect Chemother. 2020;26(6):625–632. doi:10.1016/j.jiac.2020.04.007
   PubMed Web of Science ®Google Scholar
• Gill MA, Liu AH, Calatroni A, et al. Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab. J Allergy Clin Immunol. 2018;141(5):1735–1743.e9. doi:10.1016/j.jaci.2017.07.035
   PubMed Web of Science ®Google Scholar
• Esquivel A, Busse WW, Calatroni A, et al. Effects of omalizumab on rhinovirus infections, illnesses, and exacerbations of asthma. Am J Respir Crit Care Med. 2017;196(8):985–992. doi:10.1164/rccm.201701-0120OC
   PubMed Web of Science ®Google Scholar
• García-Moguel I, Díaz Campos R, Alonso Charterina S, Fernández Rodríguez C, Fernández Crespo J. COVID-19, severe asthma, and biologics. Ann Allergy Asthma Immunol. 2020;125(3):357–359.e1. doi:10.1016/j.anai.2020.06.012
   PubMed Web of Science ®Google Scholar
• Eger K, Hashimoto S, Braunstahl GJ, et al. Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy. Respir Med. 2020;177:106287. doi:10.1016/j.rmed.2020.106287
   PubMed Web of Science ®Google Scholar
• Rial MJ, Valverde M, Del Pozo V, et al. Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak. J Allergy Clin Immunol Pract. 2021;9(1):487–489.e1. doi:10.1016/j.jaip.2020.09.050
   PubMed Web of Science ®Google Scholar
• Martha JW, Wibowo A, Pranata R. Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: a systematic review and meta-analysis. Postgrad Med J. 2021;postgradmedj-2020-139542. doi:10.1136/postgradmedj-2020-139542
   PubMed Web of Science ®Google Scholar